跳转至内容
Merck
CN
所有图片(2)

主要文件

SCNY00100

Millipore

Millipore® Steriflip® 真空管顶过滤器

pore size 100.0 μm, Nylon membrane (net), funnel capacity 50 mL, pack of 25 ea

别名:

Steriflip®无菌离心管顶部过滤装置

登录查看公司和协议定价


About This Item

UNSPSC代码:
41104914
eCl@ss:
32031602
NACRES:
NB.22

物料

Nylon membrane (net)
acrylic housing
polypropylene

质量水平

无菌性

sterile

产品线

Steriflip®

特点

holdup volume 0.6 mL
hydrophilic

包装

pack of 25 ea

参数

45 °C max. temp.

技术

sterile filtration: suitable

高度

138 mm

直径

6.4 cm

过滤器直径

4 cm

过滤面积

7 cm2

漏斗容量

50 mL

孔径

100.0 μm pore size

配件

double lead thread inlet (with vacuum port)
double lead thread outlet for 50 mL centrifuge tube

运输

ambient

一般描述

Steriflip® 过滤装置可分离较大体积的细胞材料,其附加优势在于可维持无菌环境,确保样品无菌性,这一点是开口式重力流过滤设备无法保证的。Steriflip无菌离心管顶部过滤装置可以让细胞通过同时截留大的组织块。这提高了回收率并减少了收集分离的细胞的时间。

应用

仅限研究用途。
Steriflip®无菌离心管顶过滤器已用于肿瘤获取和处理。它还用于从Balb/c小鼠提取的心脏中分离心脏干细胞(CSC)。

法律信息

Millipore is a registered trademark of Merck KGaA, Darmstadt, Germany
Steriflip is a registered trademark of Merck KGaA, Darmstadt, Germany

未找到合适的产品?  

试试我们的产品选型工具.


分析证书(COA)

输入产品批号来搜索 分析证书(COA) 。批号可以在产品标签上"批“ (Lot或Batch)字后找到。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

Jingjin Liu et al.
Experimental and therapeutic medicine, 13(6), 3348-3354 (2017-06-08)
Cardiac stem cells (CSCs) are the most promising and effective candidates for the therapy of cardiac regenerative diseases; however, they have marked limitations. For instance, the implantation of CSCs is hampered by factors such as their sustainability and long-term durability.
Steven D Forsythe et al.
Clinical cancer research : an official journal of the American Association for Cancer Research, 27(18), 5141-5150 (2021-07-03)
Immunotherapy efficacy data on appendiceal cancer from clinical trials does not exist, due to appendiceal cancer incidence of 0.97 per 100,000. The goal of this study was to preclinically explore the application of immunotherapy in treating appendiceal cancer in a
Steven Forsythe et al.
Annals of biomedical engineering, 48(3), 940-952 (2019-04-26)
Colorectal cancer is subject to a high rate of mutations, with late stage tumors often containing many mutations. These tumors are difficult to treat, and even with the recently implemented methods of personalized medicine at modern hospitals aiming to narrow
Steven D Forsythe et al.
Annals of surgical oncology, 27(13), 4950-4960 (2020-07-08)
Chemotherapy dosing duration and perfusion temperature vary significantly in HIPEC protocols. This study investigates patient-derived tumor organoids as a platform to identify the most efficacious perfusion protocol in a personalized approach. Peritoneal tumor tissue from 15 appendiceal and 8 colon

商品

可生成组织和干细胞来源3D脑、胃肠道、肺和癌症肿瘤类器官模型的类器官培养产品。

Organoid culture products to generate tissue and stem cell derived 3D brain, intestinal, gut, lung and cancer tumor organoid models.

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系技术服务部门